DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cortisporin-TC (Colistin Sulfate / Neomycin Sulfate / Thonzonium Bromide / Hydrocortisone Acetate Otic) - Summary

 
 



CORTISPORIN-TC SUMMARY

Cortisporin-TC Otic Suspension with Neomycin and Hydrocortisone (colistin sulfate, neomycin sulfate, thonzonium bromide, hydrocortisone acetate otic suspension) is a sterile antibacterial and anti-inflammatory aqueous suspension containing in each mL: Colistin base activity, 3 mg (as the sulfate); Neomycin base activity, 3.3 mg (as the sulfate); Hydrocortisone acetate, 10 mg (1%); Thonzonium bromide, 0.5 mg (0.05%); Polysorbate 80, acetic acid, and sodium acetate in a buffered aqueous vehicle. Thimerosal (mercury derivative), 0.002%, is added as a preservative. It is a nonviscous liquid, buffered at pH 5, for instillation into the canal of the external ear or direct application to the affected aural skin.

Cortisporin-TC Otic Suspension is indicated for the treatment of superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics; and for the treatment of infections of mastoidectomy and fenestration cavities, caused by organisms susceptible to the antibiotics.


See all Cortisporin-TC indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Cortisporin-TC (Colistin / Neomycin / Thonzonium / Hydrocortisone Otic)

FDA approves Xtoro to treat swimmer's ear
Source: Ear, Nose and Throat News From Medical News Today [2014.12.24]
The U.S. Food and Drug Administration has approved Xtoro (finafloxacin otic suspension), a new drug used to treat acute otitis externa, commonly known as swimmer's ear.

more news >>


Page last updated: 2014-12-24

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014